Skip to main content
Log in

Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: This study was designed to select the best monoclonal antibody to stain malignant cells in peritoneal wash fluid, and to investigate the incidence of free malignant cells in preresection and postresection colorectal cancer peritoneal washings using a combination of conventional cytology and immunocytochemistry. METHODS: Peritoneal washings were taken from 35 consecutive patients undergoing colorectal cancer resection. RESULTS: Malignant cells were isolated on a density gradient and identified by conventional cytology and an indirect immunoperoxidase stain. Malignant cells were identified in peritoneal washings from 15 patients (preresection only n=3, postresection only n=4, both n= 8). The origin of free malignant peritoneal cells in 11 preresection-positive washings must be the serosa. The origin of these cells in the four postresection-positive patients is uncertain: serosal and luminal spillage were considered unlikely and no circulating cells were found in the mesenteric vessels near the tumor. CONCLUSION: Tumor cells may have leaked out from lymphatics cut during the dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following “curative” surgery for large bowel cancer: 1. The overall picture. Br J Surg 1984;71:12–1.

    PubMed  CAS  Google Scholar 

  2. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 1982;69:613–6.

    PubMed  CAS  Google Scholar 

  3. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;1:996–9.

    Article  Google Scholar 

  4. Goligher JC, Dukes CE, Bussey HJ. Local recurrences after sphincter-saving excisions for carcinoma of the rectum and rectosigmoid. Br J Surg 1951;39:199–211.

    PubMed  CAS  Google Scholar 

  5. Williamson RC, Davies PW, Bristol JB, Wells M. Intestinal adaptation and experimental carcinogenesis after partial colectomy. Gut 1982;23:316–25.

    PubMed  CAS  Google Scholar 

  6. Oakland DJ. The diagnosis of carcinoma of the colon by exfoliative cytology. J R Soc Med 1964;57:279–82.

    CAS  Google Scholar 

  7. Keynes WM. Implantation from the bowel lumen in cancer of the large intestine. Ann Surg 1961;153:357–64.

    PubMed  CAS  Google Scholar 

  8. McGrew EA, Laws JF, Cole WH. Free malignant cells in relation to recurrence of carcinoma of the colon. JAMA 1954;154:1251–4.

    CAS  Google Scholar 

  9. Ambrose NS, MacDonald F, Young J, Thompson H, Keighley MR. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer—can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99–102.

    PubMed  CAS  Google Scholar 

  10. Cohn I. Implantation in cancer of the colon. Surg Gynecol Obstet 1967;20:501–6.

    Google Scholar 

  11. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659–63.

    PubMed  CAS  Google Scholar 

  12. Quan SH. Cul-de-sac smears for cancer cells. Surgery 1959;45:258–63.

    PubMed  CAS  Google Scholar 

  13. Gricouroff G. Pathogenesis of recurrences on the suture line following surgical resection for carcinoma of the colon. Cancer 1967:20:673–6.

    PubMed  CAS  Google Scholar 

  14. Turnbull RB, Kyle K, Warson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420–7.

    PubMed  Google Scholar 

  15. Drewinko B, Romsdahl MM, Yang L-Y, Ahearn MJ, Trujillo JM. Establishment of a human carcinoembryonic antigen producing colon adenocarcinoma cell line. Cancer Res 1976;36:467–75.

    PubMed  CAS  Google Scholar 

  16. Leibovitz A, Stinson JC, McCombs WB, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976;36:4562–9.

    PubMed  CAS  Google Scholar 

  17. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213–9.

    PubMed  CAS  Google Scholar 

  18. Arklie J. Studies of the human epithelial cell surface using monoclonal antibodies [Thesis]. Oxford, UK: University of Oxford, 1981.

    Google Scholar 

  19. Makin CA. Monoclonal antibodies raised to colorectal carcinoma antigens. Ann R Coll Surg Engl 1986;68:298–301.

    PubMed  CAS  Google Scholar 

  20. Yiu C-Y. A search for monoclonal antibodies for the immunolocalization of colorectal cancer [Thesis]. London, UK: University of London, 1989.

    Google Scholar 

  21. Richman PI, Bodmer WF. Monoclonal antibodies to human colorectal epithelium:markers for differentiation and tumour characterization. Int J Cancer 1987;39:317–28.

    PubMed  CAS  Google Scholar 

  22. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 1981;28:17–21.

    PubMed  CAS  Google Scholar 

  23. Heyderman E, Steele K, Ormerod MG. A new antigen on the epithelial membrane; its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol 1979;32:35–9.

    PubMed  CAS  Google Scholar 

  24. Burchell J, Gendler S, Taylor-Papadimitriou J,et al. Development and characterization of breast cancer reactive monoclonal antibodies to the core protein of the human milk mucin. Cancer Res 1987;47:5476–82.

    PubMed  CAS  Google Scholar 

  25. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773–81.

    PubMed  CAS  Google Scholar 

  26. Keettel WC, Pixley EE, Buchsbaum HJ. Experience with peritoneal cytology in the management of gynecologic malignancies. Am J Obstet Gynecol 1974;120:174–82.

    PubMed  CAS  Google Scholar 

  27. Creasman WT, Disaia PJ, Blessing J, Wilkinson RH, Johnston W, Weed JC. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921–7.

    PubMed  CAS  Google Scholar 

  28. Szpak CA, Creasman WT, Vollmer RT, Johnston WW. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. Acta Cytol 1981;5:640–6.

    Google Scholar 

  29. Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumours: Potential sources of error in cytologic diagnosis. Acta Cytol 1985;29:310–6.

    PubMed  CAS  Google Scholar 

  30. Grillo D, Stienmer RH, Lowell DM. Early diagnosis of ovarian carcinoma by culdocentesis. Obstet Gynecol 1966;28:346–50.

    PubMed  CAS  Google Scholar 

  31. Ravinsky E. Cytology of peritoneal washings in gynecologic patients: diagnostic criteria and pitfalls. Acta Cytol 1986;30:8–16.

    PubMed  CAS  Google Scholar 

  32. Ziselman EM, Harkavy SE, Hogan M, West M, Atkinson B. Peritoneal washing cytology: uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105–10.

    PubMed  CAS  Google Scholar 

  33. Zuna RE, Mitchell ML. Cytologic findings in peritoneal washings associated with benign gynecologic disease. Acta Cytol 1988;32:139–47.

    PubMed  CAS  Google Scholar 

  34. Kocjan G, Sweeney E, Miller KD, Bobrow L. AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids. J Clin Pathol 1992;45:358–9.

    PubMed  CAS  Google Scholar 

  35. Epenetos AA, Canti G, Taylor-Papadimitriou J, Curling M, Bodmer WF. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet 1982;1:1004–6.

    Article  PubMed  Google Scholar 

  36. Sheibani K, Shin SS, Keririan J, Weiss LW. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779–84.

    Article  PubMed  CAS  Google Scholar 

  37. Soothay GN, Griffiths M, Papadaki L, Happerfield L, Bobrow L. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation. J Pathol 1991;163:299–305.

    Article  PubMed  Google Scholar 

  38. Skipper D, Cooper AJ, Marston JE, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer Br J Surg 1987;74:1049–52.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by The Imperial Cancer Research Fund. Read in part at the meeting of the British Society of Gastroenterology, London, United Kingdom, September 25 to 27, 1991.

About this article

Cite this article

Leather, A.J.M., Kocjan, G., Savage, F. et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 37, 814–819 (1994). https://doi.org/10.1007/BF02050147

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02050147

Key words

Navigation